The Histone Demethylase LSD1 Regulates B Cell Proliferation and Plasmablast Differentiation

被引:37
|
作者
Haines, Robert R. [1 ]
Barwick, Benjamin G. [1 ,2 ]
Scharer, Christopher D. [1 ]
Majumder, Parimal [1 ]
Randall, Troy D. [1 ,3 ]
Boss, Jeremy M. [1 ]
机构
[1] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
[3] Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA
来源
JOURNAL OF IMMUNOLOGY | 2018年 / 201卷 / 09期
基金
美国国家卫生研究院;
关键词
GENE-EXPRESSION; UP-REGULATION; MOUSE; CHROMATIN; ELEMENTS; SURVIVAL; BLIMP-1; IMMUNE; CIITA; IGM;
D O I
10.4049/jimmunol.1800952
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
B cells undergo epigenetic remodeling as they differentiate into Ab-secreting cells (ASC). LSD1 is a histone demethylase known to decommission active enhancers and cooperate with the ASC master regulatory transcription factor Blimp-1. The contribution of LSD1 to ASC formation is poorly understood. In this study, we show that LSD1 is necessary for proliferation and differentiation of mouse naive B cells (nB) into plasmablasts (PB). Following LPS inoculation, LSD1-deficient hosts exhibited a 2-fold reduction of splenic PB and serum IgM. LSD1-deficient PB exhibited derepression and superinduction of genes involved in immune system processes; a subset of these being direct Blimp-1 target-repressed genes. Cell cycle genes were globally downregulated without LSD1, which corresponded to a decrease in the proliferative capacity of LSD1-deficient activated B cells. PB lacking LSD1 displayed increased histone H3 lysine 4 monomethylation and chromatin accessibility at nB active enhancers and the binding sites of transcription factors Blimp-1, PU.1, and IRF4 that mapped to LSD1-repressed genes. Together, these data show that LSD1 is required for normal in vivo PB formation, distinguish LSD1 as a transcriptional rheostat and epigenetic modifier of B cell differentiation, and identify LSD1 as a factor responsible for decommissioning nB active enhancers.
引用
收藏
页码:2799 / 2811
页数:13
相关论文
共 50 条
  • [31] The histone demethylase LSD1 regulates inner ear progenitor differentiation through interactions with Pax2 and the NuRD repressor complex
    Patel, Dharmeshkumar
    Shimomura, Atsushi
    Majumdar, Sreeparna
    Holley, Matthew C.
    Hashino, Eri
    PLOS ONE, 2018, 13 (01):
  • [32] Tetrahydropyridine derivatives: Novel and potent histone demethylase LSD1 inhibitors
    Callery, Patrick S.
    Wichitnithad, Wisut
    Borysiewicz, Elizabeth
    Konat, Gregory W.
    Konat, Gregory W.
    CANCER RESEARCH, 2011, 71
  • [33] Uncoupling histone modification crosstalk by engineering lysine demethylase LSD1
    Lee, Kwangwoon
    Barone, Marco
    Waterbury, Amanda L.
    Jiang, Hanjie
    Nam, Eunju
    DuBois-Coyne, Sarah E.
    Whedon, Samuel D.
    Wang, Zhipeng A.
    Caroli, Jonatan
    Neal, Katherine
    Ibeabuchi, Brian
    Dhoondia, Zuzer
    Kuroda, Mitzi I.
    Liau, Brian B.
    Beck, Samuel
    Mattevi, Andrea
    Cole, Philip A.
    NATURE CHEMICAL BIOLOGY, 2025, 21 (02) : 227 - 237
  • [34] Isoprenaline Inhibits Histone Demethylase LSD1 to Induce Cardiac Hypertrophy
    Wu, Lili
    Yang, Bo
    Sun, Yingze
    Fan, Guanwei
    Ma, Lina
    Ma, Ying
    Xiong, Xianjia
    Zhou, Hui
    Wang, Huiping
    Zhang, Ling
    Yang, Bing
    CARDIOVASCULAR TOXICOLOGY, 2025, 25 (01) : 34 - 47
  • [35] Regulation of LSD1 histone demethylase activity by its associated factors
    Shi, YJ
    Matson, C
    Lan, F
    Iwase, S
    Baba, T
    Shi, Y
    MOLECULAR CELL, 2005, 19 (06) : 857 - 864
  • [36] Solution structure of the SWIRM domain of human histone demethylase LSD1
    Tochio, N
    Umehara, T
    Koshiba, S
    Inoue, M
    Yabuki, T
    Aoki, M
    Seki, E
    Watanabe, S
    Tomo, Y
    Hanada, M
    Ikari, M
    Sato, M
    Terada, T
    Nagase, T
    Ohara, O
    Shirouzu, M
    Tanaka, A
    Kigawa, T
    Yokoyama, S
    STRUCTURE, 2006, 14 (03) : 457 - 468
  • [37] Targeting Histone Demethylase LSD1/KDM1a in Neurodegenerative Diseases
    Ambrosio, Susanna
    Majello, Barbara
    JOURNAL OF EXPERIMENTAL NEUROSCIENCE, 2018, 12
  • [38] The histone demethylase LSD1/KDM1A as therapeutic target in AML
    Berg, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 272 - +
  • [39] Histone Demethylase LSD1 Is Required to Repress Hematopoietic Stem Cell Signatures in Mature Blood Cells to Permit Terminal Differentiation
    Kerenyi, Marc A.
    Hsu, Jessica
    Shao, Zhen
    Orkin, Stuart H.
    BLOOD, 2011, 118 (21) : 254 - 254
  • [40] A requirement for Lysine-specific histone demethylase 1A (Lsd1) for T cell development
    Stamos, Daniel
    Li, Liqi
    Rosenfeld, Michael
    Love, Paul E.
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):